US · Healthcare

RAPT Therapeutics Inc (RAPT)

Biotechnology

RAPT Therapeutics Inc (RAPT) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RAPT

P/E ratio

18.00

RAPT Therapeutics Inc (RAPT) — FAQ

What is RAPT's P/E ratio?

The price-to-earnings (P/E) ratio for RAPT Therapeutics Inc (RAPT) is 18.00 (data as of 2026-03-24).

Does RAPT Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for RAPT Therapeutics Inc (RAPT). Check the MyAverix Finance app for the latest dividend data.

What sector is RAPT Therapeutics Inc in?

RAPT Therapeutics Inc (RAPT) is classified in the Healthcare sector (Biotechnology industry).

What exchange is RAPT listed on?

RAPT is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)